Medgend Icon

Ledgend of Medicine







discontinued


Mining

Our environment affects our health. If parts of the environment, like the air, water, or soil become polluted, it can lead to health problems. For example, asthma pollutants and chemicals in the air or in the home can trigger asthma attacks.

Some environmental risks are a part of the natural world, like radon in the soil. Others are the result of human activities, like lead poisoning from paint, or exposure to asbestos or mercury from mining or industrial use.

NIH: National Institute of Environmental Health Sciences

Mining FDA Approved Drugs

AFREZZA [Insulin Recombinant Human]
RX
-
12 units/inh (inhalation powder)
4 units/inh (inhalation powder)
8 units/inh (inhalation powder)
MannkindApr 17, 2015
  • Administration of a composition comprising insulin complexed with a diketopiperazine..
  • Administration of a composition comprising insulin complexed with microparticles of a diketopiperazine..
  • Administration of fdkp microparticles comprising insulin..
  • Method of aerosolizing/deagglomerating an insulin dry powder for use in treating diabetes mellitus via oral inhalation using an inhaler with a cartridge containing the insulin dry powder..
  • Method of controlling glycemia in diabetics by administering an initial dose of insulin-fdkp with a meal; determining blood glucose level 1-2 hrs after and administering a supplemental dose of insulin-fdkp if postprandial glucose level is >140 mg/dl.
  • Method of delivering to a patient with diabetes mellitus in a single inhalation, greater than 75% of a dry powder dose comprising insulin and fumaryl diketopiperazine using a high resistance to flow dry powder inhaler..
  • Pulmonary administration of a compisition comprising insulin bound to a diketopiperazine..
  • Pulmonary administration of a composition comprising insulin bound to a complexing agent..
  • Pulmonary administration of an insulin composition comprising fdkp at the beginning of a meal to a patient also being treated with a long-acting insulin..
  • Treatment of a patient having diabetes mellitus with a prandial rapid acting insulin..
  • Treatment of diabetes mellitus with an inhaled insulin to improve glycemic control using a dry powder inhalation system comprising an inhaler, a cartridge and a dry powder medicament comprising insulin in a single inhalation.
  • Treatment of patient having diabetes mellitus via oral inhalation of fdkp microparticles comprising insulin.
  • Use of an inhaler to administer dry powder medicament.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

WARNING: Consult a licensed physician in the appropriate field for medical treatment and drug prescription. Do not self medicate.